BioSpace News Archive

Deals

PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

January 26, 2022
·
25 min read
Business

Flatiron Health Announces RWD Partnership With Japan’s NCCHE

Flatiron Health Ⓡ today announced a partnership with Japan’s National Cancer Center Hospital East (NCCHE) to build a real-world database of patients with gastro-intestinal cancers.

January 26, 2022
·
3 min read
BiondVax to Present at Edison Group’s Open House Conference

BiondVax Pharmaceuticals Ltd. announced that it is presenting at the Edison Open House: Global Healthcare 2022 conference.

January 26, 2022
·
3 min read
Pharm Country

Hepion Pharmaceuticals’ Rencofilstat, in Combination with an Immune Checkpoint Inhibitor, Demonstrates Synergistic Anti-Tumor Activity in a Nonclinical Liver Cancer Study

Hepion Pharmaceuticals, Inc. today announced the results of a nonclinical research study showing that its clinical phase drug candidate, rencofilstat (CRV431), synergistically decreased liver tumor growth and extended mouse survival when combined with an anti-PD1 antibody, an immune checkpoint inhibitor (“ICI”).

January 26, 2022
·
7 min read
Business

Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer

Adaptimmune Therapeutics plc today announces the appointment of Cintia Piccina as Chief Commercial Officer effective January 31, 2022.

January 26, 2022
·
3 min read
Drug Development

Vaccinex Reports Two Complete Responses in First Three Patients Enrolled in the Phase 1b/2 KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA

Vaccinex, Inc. today reported positive interim response data in the Phase Ib segment of the KEYNOTE-B84 study of Vaccinex’s pepinemab in combination with Merck’s anti-PD-1 therapy Keytruda.

January 26, 2022
·
7 min read
Aeterna Zentaris Provides Business Outlook and Outlines Pipeline Priorities

Aeterna Zentaris Inc. today provided a corporate update and business outlook.

January 26, 2022
·
15 min read
Business

Adlai Nortye Announces Global License-out Agreement with Biotime for Several Products Including PD-L1 Inhibitor (AN4005) and Anti-hTNFR2 Antibody (AN3025)

Adlai Nortye Ltd. announced that it has entered into a Global License Agreement with Xiamen Biotime Biotechnology Co., Ltd. (“Biotime”) for several compounds.

January 26, 2022
·
4 min read
Healthcare Chatbots Market: The evolving paradigm of e-health has shaped the growth trajectories of the market

The use cases of medical chatbots have grown considerable over the past few decades.

January 26, 2022
·
6 min read
Elder Care Market: Rise in prevalence of chronic diseases and other disorders to drive the market

The prevalence of chronic diseases and other disorders is increasing rapidly across the globe.

January 26, 2022
·
5 min read